Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
T J WalshE J Anaissie

Abstract

The safety and antifungal efficacy of amphotericin B lipid complex (ABLC) were evaluated in 556 cases of invasive fungal infection treated through an open-label, single-patient, emergency-use study of patients who were refractory to or intolerant of conventional antifungal therapy. All 556 treatment episodes were evaluable for safety. During the course of ABLC therapy, serum creatinine levels significantly decreased from baseline (P < .02). Among 162 patients with serum creatinine values > or = 2.5 mg/dL at the start of ABLC therapy (baseline), the mean serum creatinine value decreased significantly from the first week through the sixth week (P < or = .0003). Among the 291 mycologically confirmed cases evaluable for therapeutic response, there was a complete or partial response to ABLC in 167 (57%), including 42% (55) of 130 cases of aspergillosis, 67% (28) of 42 cases of disseminated candidiasis, 71% (17) of 24 cases of zygomycosis, and 82% (9) of 11 cases of fusariosis. Response rates varied according to the pattern of invasive fungal infection, underlying condition, and reason for enrollment (intolerance versus progressive infection). These findings support the use of ABLC in the treatment of invasive fungal infections in pa...Continue Reading

Citations

Sep 28, 2004·Indian Journal of Pediatrics·Walid Abuhammour, Rashed A Hasan
Nov 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Z A KanafaniS S Kanj
Apr 20, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S B GiroisB G P Revol
Feb 16, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S B GiroisB G P Revol
Mar 29, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M ChayakulkeereeJ R Perfect
Aug 13, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J W HiemenzT J Walsh
Aug 13, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Guarro
Sep 14, 2002·Current Infectious Disease Reports·Brad Spellberg, John E. Edwards
Feb 11, 2011·Current Infectious Disease Reports·Brad Spellberg, Ashraf S Ibrahim
Mar 3, 2011·Current Infectious Disease Reports·Michael Dan
Jun 12, 2012·Current Infectious Disease Reports·Maria N GamaletsouThomas J Walsh
Nov 30, 2000·Current Infectious Disease Reports·A V Jacobs, H L Leaf
Nov 30, 2000·Current Infectious Disease Reports·C M Toscano, W R Jarvis
Aug 3, 2010·International Journal of Surgery·Rewati Raman Sharma
Jul 18, 2003·Clinical Therapeutics·Jane P BarrettUNKNOWN Amphotericin B Systematic Review Study Group
Dec 28, 1999·The Journal of Infection·A PaugamJ Dupouy-Camet
Oct 13, 1999·Neurologic Clinics·L E Davis
Sep 15, 2000·Infectious Disease Clinics of North America·D P KontoyiannisG P Bodey
Oct 29, 2000·International Journal of Antimicrobial Agents·B E De Pauw
Apr 3, 2001·International Journal of Antimicrobial Agents·I M Hann, H G Prentice
Dec 4, 2003·The Lancet Infectious Diseases·Philippe EggimannDidier Pittet
Apr 15, 2010·The Journal of Laryngology and Otology·K KulendraD Howard
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·K A Marr, R A Bowden
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·T J Walsh, A H Groll
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·M TiphineR Herbrecht
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·M Ellis
Jun 3, 1999·British Journal of Haematology·A Clark, I M Franklin
Sep 1, 1999·British Journal of Haematology·S SallahP Vos
Aug 23, 2005·Medical Mycology·W J Steinbach
May 19, 2007·Medical Mycology·Joshua PerlrothBrad Spellberg
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R WingardJ Lister
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M Rowles, S L Fraser
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J Winston, G J Schiller
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W E Dismukes
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A StevensG A Pankey
Jun 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D P KontoyiannisK V Rolston
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J Winston, G J Schiller
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D P KontoyiannisK V Rolston
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexT Wu
Oct 6, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A VillanuevaC A Sable
Jan 25, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W DenningHartmut Lode
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F Patterson
Nov 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T ChouakiC Hennequin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

© 2022 Meta ULC. All rights reserved